Search

Your search keyword '"Potier, E."' showing total 99 results

Search Constraints

Start Over You searched for: Author "Potier, E." Remove constraint Author: "Potier, E."
99 results on '"Potier, E."'

Search Results

58. Therapeutic application of mesenchymal stem cells in orthopaedics

59. Analysis of the Anthropogenic and Biogenic NOxEmissions Over 2008–2017: Assessment of the Trends in the 30 Most Populated Urban Areas in Europe

60. Les origines populaires de l’Art

61. Medical aspects of ketone body metabolism

64. Effects of shear stress on mesenchymal stem cells of patients with osteogenesis imperfecta.

65. Estradiol-17β and bisphenol A affect growth and mineralization in early life stages of seabass.

66. Porosity and surface curvature effects on the permeability and wall shear stress of trabecular bone: Guidelines for biomimetic scaffolds for bone repair.

67. Analysis of a Chronic Lateral Ankle Instability Model in the Rat: Conclusions and Suggestions for Future Research.

68. Glucose depletion decreases cell viability without triggering degenerative changes in a physiological nucleus pulposus explant model.

69. Enzyme-controlled, nutritive hydrogel for mesenchymal stromal cell survival and paracrine functions.

70. Combining biomimetic collagen/hyaluronan hydrogels with discogenic growth factors promotes mesenchymal stroma cell differentiation into Nucleus Pulposus like cells.

71. The Lower in Vivo Osteogenicity of Adipose Tissue-Derived Stem Cells Correlates with a Higher Innate Immune Response.

72. A New Microarchitecture-Based Parameter to Predict the Micromechanical Properties of Bone Allografts.

73. Glucose Metabolism: Optimizing Regenerative Functionalities of Mesenchymal Stromal Cells Postimplantation.

74. Three-dimensional Printing of Biomimetic Titanium Mimicking Trabecular Bone Induces Human Mesenchymal Stem Cell Proliferation: An In-vitro Analysis.

75. Osteogenic-differentiated mesenchymal stem cell-secreted extracellular matrix as a bone morphogenetic protein-2 delivery system for ectopic bone formation.

76. Custom-made macroporous bioceramic implants based on triply-periodic minimal surfaces for bone defects in load-bearing sites.

77. Understanding and leveraging cell metabolism to enhance mesenchymal stem cell transplantation survival in tissue engineering and regenerative medicine applications.

78. Osteogenic potential of adipogenic predifferentiated human bone marrow-derived multipotent stromal cells for bone tissue-engineering.

79. Osteogenic protein 1 does not stimulate a regenerative effect in cultured human degenerated nucleus pulposus tissue.

80. The Regenerative Potential of Notochordal Cells in a Nucleus Pulposus Explant.

81. Reduced tonicity stimulates an inflammatory response in nucleus pulposus tissue that can be limited by a COX-2-specific inhibitor.

82. Effect of coculturing canine notochordal, nucleus pulposus and mesenchymal stromal cells for intervertebral disc regeneration.

83. Conditioned medium derived from notochordal cell-rich nucleus pulposus tissue stimulates matrix production by canine nucleus pulposus cells and bone marrow-derived stromal cells.

84. Can notochordal cells promote bone marrow stromal cell potential for nucleus pulposus enrichment? A simplified in vitro system.

85. Potential application of notochordal cells for intervertebral disc regeneration: an in vitro assessment.

86. Using notochordal cells of developmental origin to stimulate nucleus pulposus cells and bone marrow stromal cells for intervertebral disc regeneration.

87. The effect of a cyclooxygenase 2 inhibitor on early degenerated human nucleus pulposus explants.

88. Long-term culture of bovine nucleus pulposus explants in a native environment.

89. Sustained and promoter dependent bone morphogenetic protein expression by rat mesenchymal stem cells after BMP-2 transgene electrotransfer.

90. Assessment of cell viability in three-dimensional scaffolds using cellular auto-fluorescence.

91. Culturing bovine nucleus pulposus explants by balancing medium osmolarity.

92. Accuracy of three techniques to determine cell viability in 3D tissues or scaffolds.

93. Desferrioxamine-driven upregulation of angiogenic factor expression by human bone marrow stromal cells.

94. Prolonged hypoxia concomitant with serum deprivation induces massive human mesenchymal stem cell death.

95. Hypoxia affects mesenchymal stromal cell osteogenic differentiation and angiogenic factor expression.

96. Synthesis and biological evaluation of novel NK-1 tachykinin receptor antagonists: the use of cycloalkyl amino acids as a template.

97. Medical aspects of ketone body metabolism.

98. Comparison of tachykinin NK1 and NK2 receptors in the circular muscle of the guinea-pig ileum and proximal colon.

99. Comparison of tachykinin NK1 receptors in human IM9 and U373 MG cells, using antagonist (FK888, (+/-)-CP-96,345, and RP 67580) binding.

Catalog

Books, media, physical & digital resources